Apta任命Gael Touya为首席执行官

2026-03-18 05:09

AptarGroup (ATR) announced on Tuesday that Gael Touya has been appointed president and chief executive officer, effective September 1, 2026.
The company said that Touya, who has served as president of Aptar Pharma since 2018, will succeed Stephan B. Tanda, who has served as president and chief executive officer since 2017.
Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to retire from Aptar’s Board by the end of 2026, and the Board will appoint Gael as a director on September 1, 2026, it added.
Source: Press Release

More on AptarGroup